UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase I and pharmacokinetic study of lapatinib in combination with infusional 5-fluorouracil, leucovorin and irinotecan

Annals of oncology, 2007-12, Vol.18 (12), p.2025-2029

2007

Volltextzugriff (PDF)

Phase II randomized trial of vinorelbine and gemcitabine versus carboplatin and paclitaxel in advanced non-small-cell lung cancer

Annals of oncology, 2005-01, Vol.16 (1), p.97-101

2005

Volltextzugriff (PDF)

431 POSTER A phase I first-in-human study of the polo-like kinase 1-selective inhibitor, GSK461364, in patients with advanced solid tumors

European journal of cancer supplements, 2008, Vol.6 (12), p.135-136

2008

Volltextzugriff (PDF)

When Domestic Violence Turns into Workplace Violence: Organizational Impact and Response

Journal of police crisis negotiations, 2009-07, Vol.9 (2), p.141-148

2009

Volltextzugriff (PDF)

Workplace Violence: Vicarious Trauma in the Psychiatric Setting

Journal of police crisis negotiations, 2006-06, Vol.6 (2), p.79-103

Versola-Russo, Judy M.

2006

Volltextzugriff (PDF)

Vicarious Victims of Trauma: A Literature Review

Journal of police crisis negotiations, 2005-09, Vol.5 (2), p.59-80

Versola-Russo, Judy M.

2005

Volltextzugriff (PDF)

Phase I study of GW572016 (lapatinib), a dual kinase inhibitor, in combination with irinotecan (IR), 5-fluorouracil (FU) and leucovorin (LV)

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.3086-3086

2005

Volltextzugriff (PDF)

Phase I clinical, biology & pharmacokinetic study of the combination of GW 572016 and capecitabine in patients with advanced solid tumors

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3070-3070

2004

Volltextzugriff (PDF)

Phase I clinical, biology & pharmacokinetic study of the combination of GW 572016 and capecitabine in patients with advanced solid tumors

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3070-3070

2004

Volltextzugriff (PDF)

A safety, tolerability, and pharmacokinetic (PK) study of GW572016 in patients with solid tumors

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3179-3179

2004

Volltextzugriff (PDF)

A safety, tolerability, and pharmacokinetic (PK) study of GW572016 in patients with solid tumors

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3179-3179

2004

Volltextzugriff (PDF)

Phase I trial to determine the safety and tolerability of GW572016 in combination with oxaliplatin (OX)/5-fluorouracil (5-FU)/leucovorin (LV) [FOLFOX4] in patients with solid tumors

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.2044-2044

2004

Volltextzugriff (PDF)

Phase I trial to determine the safety and tolerability of GW572016 in combination with oxaliplatin (OX)/5-fluorouracil (5-FU)/leucovorin (LV) [FOLFOX4] in patients with solid tumors

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.2044-2044

2004

Volltextzugriff (PDF)

Clinical activity of GW572016 in EGF10003 in patients with solid tumors

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3047-3047

2004

Volltextzugriff (PDF)

Clinical activity of GW572016 in EGF10003 in patients with solid tumors

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3047-3047

2004

Volltextzugriff (PDF)

A Pilot Study of Edrecolomab (Panorex, 17-1A Antibody) and Capecitabine in Patients with Advanced or Metastatic Adenocarcinoma

Cancer investigation, 2003-01, Vol.21 (2), p.177-184

2003

Volltextzugriff (PDF)

A phase I study of the dual kinase inhibitor GW572016 in combination with paclitaxel (EGF10009)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.2083-2083

2004

Volltextzugriff (PDF)

A phase I study of the dual kinase inhibitor GW572016 in combination with paclitaxel (EGF10009)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.2083-2083

2004

Volltextzugriff (PDF)

559 Pharmacokinetics of GW572016 in an ascending dose tolerability study of phase I cancer patients

European journal of cancer supplements, 2003-09, Vol.1 (5), p.S169-S169

2003

Volltextzugriff (PDF)

558 The effect of food on the pharmacokinetics of GW572016

European journal of cancer supplements, 2003-09, Vol.1 (5), p.S169-S169

2003

Volltextzugriff (PDF)

Workplace violence: Vicarious victims of trauma in the psychiatric setting

Versola-Russo, Judy M

2004

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of Oral Lapatinib Administered Once or Twice Daily in Patients with Solid Malignancies

Clinical cancer research, 2009-11, Vol.15 (21), p.6702-6708

2009

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Lapatinib in Combination With Capecitabine in Patients With Advanced Solid Malignancies

Journal of clinical oncology, 2007-08, Vol.25 (24), p.3753-3758

2007

Volltextzugriff (PDF)

Phase I Pharmacokinetic Study of the Safety and Tolerability of Lapatinib (GW572016) in Combination with Oxaliplatin/Fluorouracil/Leucovorin (FOLFOX4) in Patients with Solid Tumors

Clinical cancer research, 2007-08, Vol.13 (15), p.4495-4502

2007

Volltextzugriff (PDF)

Differential activity and synthesis of lactate dehydrogenase isozymes A (muscle), B (heart), and C (testis) in mouse spermatogenic cells

Biology of reproduction, 1989, Vol.40 (1), p.173-180

1989

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(25)
Dissertationen
(1)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Zeitschrift / Serie

Journal Of Clinical Oncology
(12)
European Journal Of Cancer Supplements
(3)
Journal Of Police Crisis Negotiations
(3)
Annals Of Oncology
(2)
Clinical Cancer Research
(2)
Biology Of Reproduction
(1)
Cancer Investigation
(1)
Philippine Phytopathology
(1)

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A phase I and pharmacokinetic study of lapatinib in combination with infusional 5-fluorouracil, leucovorin and irinotecan

Phase II randomized trial of vinorelbine and gemcitabine versus carboplatin and paclitaxel in advanced non-small-cell lung cancer

431 POSTER A phase I first-in-human study of the polo-like kinase 1-selective inhibitor, GSK461364, in patients with advanced solid tumors

When Domestic Violence Turns into Workplace Violence: Organizational Impact and Response

Workplace Violence: Vicarious Trauma in the Psychiatric Setting

Vicarious Victims of Trauma: A Literature Review

Phase I study of GW572016 (lapatinib), a dual kinase inhibitor, in combination with irinotecan (IR), 5-fluorouracil (FU) and leucovorin (LV)

Phase I clinical, biology & pharmacokinetic study of the combination of GW 572016 and capecitabine in patients with advanced solid tumors

Phase I clinical, biology & pharmacokinetic study of the combination of GW 572016 and capecitabine in patients with advanced solid tumors

A safety, tolerability, and pharmacokinetic (PK) study of GW572016 in patients with solid tumors

A safety, tolerability, and pharmacokinetic (PK) study of GW572016 in patients with solid tumors

Phase I trial to determine the safety and tolerability of GW572016 in combination with oxaliplatin (OX)/5-fluorouracil (5-FU)/leucovorin (LV) [FOLFOX4] in patients with solid tumors

Phase I trial to determine the safety and tolerability of GW572016 in combination with oxaliplatin (OX)/5-fluorouracil (5-FU)/leucovorin (LV) [FOLFOX4] in patients with solid tumors

Clinical activity of GW572016 in EGF10003 in patients with solid tumors

Clinical activity of GW572016 in EGF10003 in patients with solid tumors

A Pilot Study of Edrecolomab (Panorex, 17-1A Antibody) and Capecitabine in Patients with Advanced or Metastatic Adenocarcinoma

A phase I study of the dual kinase inhibitor GW572016 in combination with paclitaxel (EGF10009)

A phase I study of the dual kinase inhibitor GW572016 in combination with paclitaxel (EGF10009)

559 Pharmacokinetics of GW572016 in an ascending dose tolerability study of phase I cancer patients

558 The effect of food on the pharmacokinetics of GW572016

Workplace violence: Vicarious victims of trauma in the psychiatric setting

A Phase I and Pharmacokinetic Study of Oral Lapatinib Administered Once or Twice Daily in Patients with Solid Malignancies

Phase I and Pharmacokinetic Study of Lapatinib in Combination With Capecitabine in Patients With Advanced Solid Malignancies

Phase I Pharmacokinetic Study of the Safety and Tolerability of Lapatinib (GW572016) in Combination with Oxaliplatin/Fluorouracil/Leucovorin (FOLFOX4) in Patients with Solid Tumors

Differential activity and synthesis of lactate dehydrogenase isozymes A (muscle), B (heart), and C (testis) in mouse spermatogenic cells

Suchergebnisse filtern